Cesca Therapeutics Inc. | Cash Flow
Fiscal year is July-June. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
3,086.00
8,631.00
14,852.00
18,588.00
29,095.00
40,940
Depreciation, Depletion & Amortization
538.00
993.00
1,351.00
1,168.00
830.00
670
Other Funds
-
150.00
-
159.00
-
35,813
Funds from Operations
3,957.00
7,362.00
12,137.00
9,566.00
6,750.00
9,187
Changes in Working Capital
875.00
474.00
1,488.00
59.00
465.00
2,204
Net Operating Cash Flow
3,082.00
7,836.00
10,649.00
9,625.00
7,215.00
6,983
Capital Expenditures
391.00
402.00
587.00
710.00
375.00
Net Investing Cash Flow
2,144.00
51.00
587.00
710.00
375.00
Issuance/Reduction of Debt, Net
-
-
60.00
10,528.00
3,416.00
Net Financing Cash Flow
57.00
15,807.00
189.00
12,824.00
5,374.00
Net Change in Cash
995.00
7,927.00
11,454.00
2,478.00
2,212.00
Free Cash Flow
3,473.00
8,238.00
11,236.00
10,335.00
7,590.00
Deferred Taxes & Investment Tax Credit
-
403.00
-
-
673.00
4,730
Net Assets from Acquisitions
-
351.00
-
-
-
Other Sources
2,535.00
-
-
-
-
Change in Capital Stock
57.00
15,957.00
129.00
2,455.00
1,958.00
Exchange Rate Effect
-
7.00
29.00
11.00
4.00
About Cesca Therapeutics
View Profile
